A carregar...
A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab
Ipilimumab is a monoclonal antibody that works as an immunotherapeutic agent through selective targeting of T cells to strengthen the response to metastatic melanoma. It is well known that this pharmaceutical agent can cause the adverse effect of colitis. We report a rare presentation of ileocolitis...
Na minha lista:
| Publicado no: | Case Rep Gastrointest Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5818971/ https://ncbi.nlm.nih.gov/pubmed/29552363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/2431503 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|